1-7 of 7
Francois Delhommeau, PharmD, PHD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clonal Architecture of Relapsed MLL-AF9 Acute Myeloid Leukemia in a Child

Hélène Boutroux, MD, Pierre Hirsch, MD, Chrystele Bilhou-Nabera, Ruoping Tang, Fanny Fava, Hélène Lapillonne, MD PhD, Guy Leverger, MD, Luc Douay, MD PhD, Francois Delhommeau, PharmD, PhD
Journal: Blood
Blood (2014) 124 (21): 1014.
https://doi.org/10.1182/blood.V124.21.1014.1014
Published: 2014
Journal Articles

Clinical Implications for Patients with Low JAK2V617F Allele Burden

Marguerite Vignon, Dorota Jeziorowska, Pierre Hirsch, MD, Ollivier Legrand, MD, PhD, Nicole Casadevall, MD, Francois Delhommeau, PharmD, PHD, Christophe Marzac, MD
Journal: Blood
Blood (2012) 120 (21): 1745.
https://doi.org/10.1182/blood.V120.21.1745.1745
Published: 2012
Journal Articles

Two Distinct Mechanisms Contribute to Granulomonocytic Hyperplasia in Chronic Myelomonocytic Leukemias (CMML)

Raphael Itzykson, Olivier Kosmider, MD, PhD, Aline Renneville, Margot Morabito, Dorothee Buet, Claude Preudhomme, Céline Berthon, MD, PhD, Lionel Ades, MD, PhD, Pierre Fenaux, MD, PhD, Uwe Platzbecker, MD, Olivier Gagey, Philippe Rameau, Francois Delhommeau, PharmD, PHD, Olivier A. Bernard, PhD, Michaela Fontenay, MD, PhD, William Vainchenker, MD, PhD, Nathalie Droin, Ph.D, Eric Solary
Journal: Blood
Blood (2012) 120 (21): 309.
https://doi.org/10.1182/blood.V120.21.309.309
Published: 2012
Journal Articles

TET2 Favors Mesoderm and Hematopoietic Differentiation in Human Embryonic Stem Cells

Barbara da Costa Reis Monte Mor, Ph.D, Thierry Langlois, Nathalie Droin, Ph.D, Elodie Pronier, Jean-Pierre Le Couédic, Nathalie Auger, M.D., Carole Almire, M.D., Thomas Mercher, PhD, Francois Delhommeau, PharmD, PhD, Debili Najet, Ph.D, Olivier Bernard, Eric Solary, Isabelle Plo, Ph.D, William Vainchenker, MD., Ph.D
Journal: Blood
Blood (2011) 118 (21): 2418.
https://doi.org/10.1182/blood.V118.21.2418.2418
Published: 2011
Journal Articles

The Cell Cycle Regulator CDC25A Is a Target for JAK2 V617F Oncogene

Emilie-Fleur Gautier, Christian Recher, MD, PHD, Camille Laurent, MD, Caroline Marty, PhD, Jean-Luc Villeval, PhD, Cécile Demur, MD, Francois Delhommeau, PharmD, PhD, Elizabeth Hexner, MD, Stephane Giraudier, MD, PhD, Nicolas Bonnevialle, MD, Bernard Ducommun, MD, PhD, Guy Laurent, MD PHD, Stéphane Manenti, PhD, Véronique Mansat- De Mas, PharmD, PhD
Journal: Blood
Blood (2011) 118 (21): 1385.
https://doi.org/10.1182/blood.V118.21.1385.1385
Published: 2011
Journal Articles

Novel Mutations: Dissecting Pathogenetic Contribution

William Vainchenker, MD, PhD, Francois Delhommeau, PharmD, PhD, Isabelle Plo, Jean-Luc Villeval, Olivier Bernard
Journal: Blood
Blood (2010) 116 (21): SCI-34.
https://doi.org/10.1182/blood.V116.21.SCI-34.SCI-34
Published: 2010
Journal Articles

Inhibition of TET2 Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine Disturbs Myelopoiesis and Granulo-Monocytic Differentiation.

Elodie Pronier, Carole Almire, Barbara da Costa Reis Monte Mor, Audrey Simon, Aline Massé, Hayat Mokrani, Nicole Casadevall, MD, Jean-Luc Ravanat, Eric Solary, William Vainchenker, MD, PhD, Isabelle Plo, Francois Delhommeau, PharmD, PhD
Journal: Blood
Blood (2010) 116 (21): 1584.
https://doi.org/10.1182/blood.V116.21.1584.1584
Published: 2010